:quality(80))
Through pre-clinical and clinical research, we develop and test medicines to ensure they are safe and effective.
Across haematology, immunotherapy and critical care, our R&D teams bring clinical and scientific expertise to the development of new therapies.
Through careful preclinical and clinical research, we work to identify new treatment options, support the safe use of our medicines, and continue improving therapies already in use.
Every new medicine starts long before it reaches a patient. In preclinical research and development, scientific ideas are tested, refined, and assessed for safety.
At Octapharma, this work is carried out at our sites in Vienna, Austria, and across Germany in Berlin, Frankfurt, and Heidelberg. Together, these sites form a collaborative network advancing scientific innovation and new therapies.
Our clinical research teams oversee studies throughout the life cycle of our medicines, working responsibly and to high scientific standards. While studies are conducted worldwide, they are primarily managed by teams in Austria, Switzerland, and the US, with support from colleagues across Octapharma.
Octapharma-sponsored clinical studies are registered in international clinical trial registries.
